Balance Sheet - ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 2,471.66 | 1,241.95 | 1,073.70 | 1,494.34 | 1,706.89 | 1,019.98 | 878.51 | 971.49 | 398.99 | 451.92 |
| Accounts receivable, net | 253.10 | 99.07 | 163.54 | 61.49 | 54.13 | 0.48 | 2.53 | 5.25 | 7.85 | 8.31 |
| Inventories | 28.64 | 6.60 | 16.17 | 9.45 | 3.93 | 0.00 | ||||
| Other current assets | 192.65 | 131.91 | 95.18 | 89.91 | 120.34 | 58.59 | 28.07 | 13.48 | 7.87 | 3.47 |
| Total current assets | 2,946.05 | 1,474.16 | 1,344.18 | 1,636.49 | 1,885.28 | 1,079.04 | 909.11 | 990.22 | 414.71 | 463.70 |
| Total non-current assets | 1,020.05 | 1,143.65 | 1,156.22 | 1,193.77 | 1,054.78 | 652.00 | 295.95 | 239.16 | 166.95 | 129.64 |
| Total assets | 3,966.10 | 2,617.81 | 2,500.39 | 2,830.26 | 2,940.06 | 1,731.04 | 1,205.05 | 1,229.38 | 581.66 | 593.34 |
| Total current liabilities | 1,644.42 | 1,166.61 | 934.17 | 881.15 | 361.11 | 276.15 | 202.06 | 105.27 | 79.54 | 77.62 |
| Total non-current liabilities | 986.62 | 1,177.04 | 1,495.59 | 1,540.45 | 1,344.21 | 608.27 | 112.51 | 2,135.69 | 633.93 | 530.33 |
| Total liabilities | 2,631.04 | 2,343.65 | 2,429.76 | 2,421.60 | 1,705.32 | 884.42 | 314.58 | 2,240.96 | 713.46 | 607.95 |
| Total stockholders' equity | 1,325.31 | 264.19 | 60.42 | 408.66 | 1,234.74 | 846.62 | 890.48 | -1,011.59 | -131.80 | -14.61 |
| Common shares outstanding | 89 | 76 | 18 | 16 | 16 | 13 | 13 | 13 | 13 | 13 |
Show Quarterly Balance Sheet
Balance Sheet - ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
$(Billion, Million)| Mar-26 | Dec-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Dec-22 | Jun-22 | Dec-21 | Jun-21 | Dec-20 | Jun-20 | Dec-19 | Jun-19 | Dec-18 | Jun-18 | Mar-18 | Dec-17 | Jun-17 | Mar-17 | Dec-16 | Jun-16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 2,471.66 | 2,471.66 | 1,661.45 | 1,236.58 | 1,236.58 | 1,266.58 | 1,100.31 | 1,100.31 | 1,069.30 | 1,100.39 | 1,581.60 | 1,475.64 | 1,698.71 | 1,706.89 | 1,531.71 | 1,019.98 | 647.64 | 878.51 | 793.93 | 971.49 | 334.81 | 50.58 | 398.99 | 425.45 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 253.10 | 253.10 | 78.36 | 99.07 | 99.07 | 83.14 | 852.81 | 743.52 | 163.54 | 145.89 | 174.22 | 61.49 | 161.51 | 54.13 | 66.34 | 0.48 | 27.14 | 2.53 | 2.65 | 5.25 | 33.27 | 5.03 | 7.85 | 8.08 | |||
| Inventories | 28.64 | 28.64 | 8.59 | 6.60 | 6.60 | 6.60 | 10.72 | 10.72 | 16.17 | 16.17 | 5.02 | 9.45 | 5.25 | 3.93 | |||||||||||||
| Other current assets | 192.65 | 192.65 | 160.31 | 131.91 | 131.91 | 117.84 | 109.29 | 95.18 | 81.73 | 89.91 | 120.34 | 58.59 | 28.07 | 32.45 | 13.48 | 11.20 | 1.69 | 7.87 | 5.67 | ||||||||
| Total current assets | 2,946.05 | 2,946.05 | 1,908.72 | 1,474.16 | 1,474.16 | 1,474.16 | 1,963.84 | 1,963.84 | 1,344.18 | 1,344.18 | 1,760.84 | 1,636.49 | 1,865.47 | 1,885.28 | 1,598.05 | 1,079.04 | 674.78 | 909.11 | 829.02 | 990.22 | 379.28 | 57.30 | 414.71 | 439.21 | |||
| Total non-current assets | 1,020.05 | 1,020.05 | 1,137.42 | 1,143.65 | 1,143.65 | 1,143.65 | 1,143.23 | 1,143.23 | 1,156.22 | 1,156.22 | 1,157.24 | 1,193.77 | 1,169.44 | 1,054.78 | 810.15 | 652.00 | 430.76 | 295.95 | 243.03 | 239.16 | 193.65 | 29.26 | 166.95 | 148.30 | |||
| Total assets | 3,966.10 | 3,966.10 | 3,046.14 | 2,617.81 | 2,617.81 | 2,617.81 | 3,107.07 | 3,107.07 | 2,500.39 | 2,500.39 | 2,918.08 | 2,830.26 | 3,034.91 | 2,940.06 | 2,408.20 | 1,731.04 | 1,105.54 | 1,205.05 | 1,072.05 | 1,229.38 | 572.94 | 86.56 | 581.66 | 587.50 | |||
| Total current liabilities | 1,644.42 | 1,644.42 | 1,239.30 | 1,166.61 | 1,166.61 | 1,166.61 | 1,065.35 | 1,065.35 | 934.17 | 934.17 | 642.88 | 881.15 | 612.30 | 361.11 | 193.79 | 276.15 | 136.69 | 202.06 | 175.09 | 105.27 | 146.63 | 22.15 | 79.54 | 78.58 | |||
| Total non-current liabilities | 986.62 | 986.62 | 1,130.93 | 1,177.04 | 1,177.04 | 1,177.04 | 1,265.28 | 1,265.28 | 1,495.59 | 1,495.59 | 1,675.03 | 1,540.45 | 1,545.76 | 1,344.21 | 764.52 | 608.27 | 356.64 | 112.51 | 2,520.46 | 2,135.69 | 627.27 | 94.77 | 633.93 | 582.13 | |||
| Total liabilities | 2,631.04 | 2,631.04 | 2,370.24 | 2,343.65 | 2,343.65 | 2,343.65 | 2,330.63 | 2,330.63 | 2,429.76 | 2,429.76 | 2,317.91 | 2,421.60 | 2,158.06 | 1,705.32 | 958.31 | 884.42 | 493.33 | 314.58 | 2,695.55 | 2,240.96 | 773.91 | 116.92 | 713.46 | 660.70 | |||
| Total stockholders' equity | 1,325.31 | 1,325.31 | 666.00 | 264.19 | 264.19 | 264.19 | 766.40 | 766.40 | 60.42 | 60.42 | 589.89 | 408.66 | 876.85 | 1,234.74 | 1,449.90 | 846.62 | 612.21 | 890.48 | -1,623.50 | -1,011.59 | -215.82 | -32.61 | -131.80 | -73.20 | |||
| Common shares outstanding | 93 | 93 | 85 | 78 | 78 | 312 | 74 | 296 | 73 | 290 | 18 | 16 | 16 | 16 | 16 | 13 | 13 | 13 | 13 | 13 | 12 | 49 | 13 | 12 | 49 | 13 | 13 |